Biotech

All Articles

ArsenalBio raises $325M, turns far from former lead asset

.Collection Biosciences is going on up. The cell therapy business has added on $325 million in ammo ...

Lilly- supported fat burning biotech files IPO

.After elevating $170 million back in February, metabolic disease-focused BioAge Labs has actually s...

Aelis' cannabis usage medication flunks phase 2b, driving Indivior to re-think $100M choice

.Aelis Farma's chances of safeguarding a simple, favorable selection on a $100 thousand choice remit...

ProKidney stops period 3 test not needed to have for tissue treatment approval

.ProKidney has actually stopped among a pair of period 3 trials for its cell therapy for renal condi...

Vaxcyte rises on 'impressive' 31-valent PCV win against Pfizer

.Vaxcyte revealed what analysts referred to as "impressive" stage 1/2 records for its own 31-valent ...

Recursion's brain ailment test reveals insufficient proof of efficiency

.Recursion has discovered with an early test of its own tech-enabled strategy to medicine discovery,...

Acepodia, Pfizer click on with each other for chemistry-based cell therapy

.Contact it a situation of great chemistry: Acepodia, a biotech based upon Nobel Champion science, i...

Praxis epilepsy medication decreases confiscations in period 2 trial

.Practice Precision Medicines has racked up an additional midphase succeed in epilepsy this year, al...

Three execs surrender as Dyne blog posts mixed data for DMD applicant

.After escaping a scientific hold many years back, Dyne Therapeutics has actually exposed brand new ...

Arrowhead fires off stage 3 information in unusual metabolic disease in advance of market encounter Ionis

.Arrowhead Pharmaceuticals has actually presented its own hand ahead of a prospective face-off along...